Literature DB >> 22776820

Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.

Takashi Asai1, Yan Liu, Silvana Di Giandomenico, Narae Bae, Delphine Ndiaye-Lobry, Anthony Deblasio, Silvia Menendez, Yevgeniy Antipin, Boris Reva, Rachel Wevrick, Stephen D Nimer.   

Abstract

We recently defined a critical role for p53 in regulating the quiescence of adult hematopoietic stem cells (HSCs) and identified necdin as a candidate p53 target gene. Necdin is a growth-suppressing protein and the gene encoding it is one of several that are deleted in patients with Prader-Willi syndrome. To define the intrinsic role of necdin in adult hematopoiesis, in the present study, we transplanted necdin-null fetal liver cells into lethally irradiated recipients. We show that necdin-null adult HSCs are less quiescent and more proliferative than normal HSCs, demonstrating the similar role of necdin and p53 in promoting HSC quiescence during steady-state conditions. However, wild-type recipients repopulated with necdin-null hematopoietic stem/progenitor cells show enhanced sensitivity to irradiation and chemotherapy, with increased p53-dependent apoptosis, myelosuppression, and mortality. Necdin controls the HSC response to genotoxic stress via both cell-cycle-dependent and cell-cycle-independent mechanisms, with the latter occurring in a Gas2L3-dependent manner. We conclude that necdin functions as a molecular switch in adult hematopoiesis, acting in a p53-like manner to promote HSC quiescence in the steady state, but suppressing p53-dependent apoptosis in response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776820      PMCID: PMC3429304          DOI: 10.1182/blood-2011-11-393983

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis.

Authors:  R Benetti; G Del Sal; M Monte; G Paroni; C Brancolini; C Schneider
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

2.  GAS2L3, a target gene of the DREAM complex, is required for proper cytokinesis and genomic stability.

Authors:  Patrick Wolter; Kathrin Schmitt; Marc Fackler; Heidi Kremling; Leona Probst; Stefanie Hauser; Oliver J Gruss; Stefan Gaubatz
Journal:  J Cell Sci       Date:  2012-02-17       Impact factor: 5.285

3.  Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair.

Authors:  Anne Wilson; Elisa Laurenti; Gabriela Oser; Richard C van der Wath; William Blanco-Bose; Maike Jaworski; Sandra Offner; Cyrille F Dunant; Leonid Eshkind; Ernesto Bockamp; Pietro Lió; H Robson Macdonald; Andreas Trumpp
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

Review 4.  The p53 tumor suppressor protein regulates hematopoietic stem cell fate.

Authors:  Takashi Asai; Yan Liu; Narae Bae; Stephen D Nimer
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

5.  The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region.

Authors:  P Jay; C Rougeulle; A Massacrier; A Moncla; M G Mattei; P Malzac; N Roëckel; S Taviaux; J L Lefranc; P Cau; P Berta; M Lalande; F Muscatelli
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

6.  Mouse development and cell proliferation in the absence of D-cyclins.

Authors:  Katarzyna Kozar; Maria A Ciemerych; Vivienne I Rebel; Hirokazu Shigematsu; Agnieszka Zagozdzon; Ewa Sicinska; Yan Geng; Qunyan Yu; Shoumo Bhattacharya; Roderick T Bronson; Koichi Akashi; Piotr Sicinski
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

7.  Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.

Authors:  Joseph M Scandura; Piernicola Boccuni; Joan Massagué; Stephen D Nimer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

8.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

9.  p53 regulates hematopoietic stem cell quiescence.

Authors:  Yan Liu; Shannon E Elf; Yasuhiko Miyata; Goro Sashida; Yuhui Liu; Gang Huang; Silvana Di Giandomenico; Jennifer M Lee; Anthony Deblasio; Silvia Menendez; Jack Antipin; Boris Reva; Andrew Koff; Stephen D Nimer
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

10.  CXCR4 is required for the quiescence of primitive hematopoietic cells.

Authors:  Yuchun Nie; Yoon-Chi Han; Yong-Rui Zou
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

View more
  26 in total

Review 1.  Genetic control of quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; H Daniel Lacorazza
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

2.  HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity.

Authors:  Wei-Kai Hua; Jing Qi; Qi Cai; Emily Carnahan; Maria Ayala Ramirez; Ling Li; Guido Marcucci; Ya-Huei Kuo
Journal:  Blood       Date:  2017-10-30       Impact factor: 22.113

3.  Epigenetic reprogramming induces the expansion of cord blood stem cells.

Authors:  Pratima Chaurasia; David C Gajzer; Christoph Schaniel; Sunita D'Souza; Ronald Hoffman
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

4.  MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling.

Authors:  Krasimira Rozenova; Jing Jiang; Ryan Donaghy; Bernadette Aressy; Roger A Greenberg; Wei Tong
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

Review 5.  The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.

Authors:  Vinod Pant; Alfonso Quintás-Cardama; Guillermina Lozano
Journal:  Blood       Date:  2012-09-27       Impact factor: 22.113

Review 6.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

7.  Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.

Authors:  Luis A Carvajal; Daniela Ben Neriah; Adrien Senecal; Lumie Benard; Victor Thiruthuvanathan; Tatyana Yatsenko; Swathi-Rao Narayanagari; Justin C Wheat; Tihomira I Todorova; Kelly Mitchell; Charles Kenworthy; Vincent Guerlavais; D Allen Annis; Boris Bartholdy; Britta Will; Jesus D Anampa; Ioannis Mantzaris; Manuel Aivado; Robert H Singer; Robert A Coleman; Amit Verma; Ulrich Steidl
Journal:  Sci Transl Med       Date:  2018-04-11       Impact factor: 17.956

8.  CDK19 regulates the proliferation of hematopoietic stem cells and acute myeloid leukemia cells by suppressing p53-mediated transcription of p21.

Authors:  Zihao Zhang; Yukai Lu; Yan Qi; Yang Xu; Song Wang; Fang Chen; Mingqiang Shen; Mo Chen; Naicheng Chen; Lijing Yang; Shilei Chen; Fengchao Wang; Yongping Su; Mengjia Hu; Junping Wang
Journal:  Leukemia       Date:  2022-02-02       Impact factor: 12.883

Review 9.  Ovarian cancer stem cells: a new target for cancer therapy.

Authors:  Qinglei Zhan; Chunmei Wang; Saiming Ngai
Journal:  Biomed Res Int       Date:  2013-01-30       Impact factor: 3.411

10.  ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.

Authors:  Shuo Yang; Xiao-Na Zhu; Hui-Lin Zhang; Qian Yang; Yu-Sheng Wei; Di Zhu; Meng-Di Liu; Shao-Ming Shen; Li Xia; Ping He; Meng-Kai Ge; Yi-Lian Pan; Meng Zhao; Ying-Li Wu; Jun-Ke Zheng; Guo-Qiang Chen; Yun Yu
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.